Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372281
Status:
UNKNOWN
Last Update Posted:
2009-02-25
First Post:
2006-09-04
Brief Title:
Cliavist in Infectious and Degenerative Diseases of the Spine
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Comparison of Cliavist Enhancement in Infectious and Degenerative Diseases of the Spine
Status:
UNKNOWN
Status Verified Date:
2009-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
USPIO contrast enhancement results from intracellular trapping of the iron particles in reactive cells especially macrophages 17FDG-PET studies have demonstrated that macrophages are present in spine infectious diseases but are absent in spine degenerative diseases The aim of this work is to compare the enhancement induced by CLIAVIST in both diseases The absence of macrophages in degenerative lesions should help to differentiate them from infectious lesions who should present contrast enhancement in relation to the presence of macrophages
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None